Dr. Reddy’s Laboratories, a Hyderabad, India-headquartered pharmaceutical company, has announced a change in the makeup of its senior leadership team.

Following a 15-year career with the company, Abhijit Mukherjee, Chief Operating Officer, will retire on March 31, 2018. Mukherjee will be succeeded by Erez Israeli, former President & Chief Executive Officer (CEO) of Enzymotec, an Israeli specialty chemicals company.

Israeli joined Dr. Reddy’s as of April 2, 2018, as Chief Operating Officer and Global Head of Generics & PSAI, based out of Hyderabad. He will report to Dr. Reddy’s Co-Chairman & CEO, G.V. Prasad.

In a career spanning over 25 years, Israeli has held multiple leadership positions. Prior to Enzymotec, he completed 23 years with Teva Pharmaceutical, where he held several positions of responsibility, including Vice President Marketing & Sales for North America, Vice President, Asia Operations, President Teva API, Group Executive Vice President, Head of Global Quality, and President & CEO. Growth Markets.

Source: Dr. Reddy’s Laboratories